Penn Capital Management Company, LLC
Position in TVTX — Travere Therapeutics, Inc.
CIK 1158202
PHILADELPHIA, PA
Position in TVTX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$376,603
-$76,835 QoQ
Shares Held
12,676
+6.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Penn Capital Management Company, LLC holds $79,843,281 across 7 Biotechnology names. TVTX ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
256,767 | $23,720,135 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
95,456 | $19,057,790 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
541,960 | $18,003,911 | |
| 4 | SLNO |
Soleno Therapeutics Inc
|
268,785 | $8,998,921 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
333,130 | $7,848,542 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,510 | $1,837,379 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
This page
|
12,676 | $376,603 |
All Filings in TVTX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $376,603 | 12,676 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $453,438 | 11,867 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $645,395 | 27,004 | Shares | Sole | 2025-11-24 | |
| 2025-06-30 | $285,995 | 19,324 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $378,004 | 21,094 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||